Medical Tribune

What Medical Tribune does

Medical Tribune Co., Ltd. (株式会社メディコス), headquartered in Tokyo's Minato-ku, is a Japanese medical media and information-services company founded in November 1967 that launched its weekly Medical Tribune newspaper in April 1968. Over five decades it has built a multi-channel platform serving Japanese healthcare professionals — physicians across all specialties as the primary audience, with secondary audiences of pharmacists, hospitals and clinics, pharmaceutical manufacturers, and medical device companies — and operates from five offices in Tokyo, Osaka, Sapporo, Fukuoka, and Nagoya.

The company's core platform is the Medical Tribune Web (medical-tribune.co.jp), a member-based content portal delivering daily medical news, clinical case reports (MT Case Reports), specialist commentaries (Doctor's Eye), conference reports, and specialty channels including Oncology Tribune and Pharma Tribune. Adjacent products include MT-MEET LIVE clinical webinars, the PubMed AI Japanese summary tool (エビでやんす / "Ebi de Yansu"), a prescription-data and drug-labeling database (添付文書・処方数量統計データ), the physician-placement service Medical Tribune Career (launched August 2016), the clinic succession brokerage Medical Tribune NEXT (launched 2019), and the MT-MEET lifelong-learning CME site. The technology stack consists of a standard web CMS with integrations to Google Analytics, Google Tag Manager, Google Search Console, Google Ad Manager, YouTube, Datadog, and Zendesk; the AI surface is a text-summarization feature layered over PubMed content, with no disclosed proprietary model or training pipeline.

Monetization follows a B2B advertising-led model targeting pharmaceutical and medical-device companies via the owned physician audience, supplemented by transaction-based professional-services streams — placement fees from healthcare facilities hiring physicians, success fees on clinic succession transactions, event and webinar production, and subscription publishing. Go-to-market combines a direct sales force to enterprise pharma customers with a self-serve platform for individual physicians (free to the doctor, paid by the hiring institution or clinic owner). The company is privately held under Representative President Osamu Horikawa (堀川 修), became independent from former German owner Süddeutscher Verlag GmbH in 2003, and most recently entered a strategic business partnership with pharmaceutical wholesaler Alfresa Corporation announced June 1, 2026.

Name

Medical Tribune

Legal name

株式会社 медиcos

Website

https://medical-tribune.co.jp

Company type

Private

Founded year

1967

Operating status

Operating

Short description

Medical Tribune is a Japanese medical media company founded in 1967 that publishes a physician-focused web platform and weekly newspaper, monetizing its registered physician community through pharma advertising, recruitment placement fees, clinic succession brokerage, and continuing medical education.

Ownership category

akta.pro rank

Product category

Medical Publishing

NAICS

Newspaper, Periodical, Book, and Directory Publishers (5131)

SIC

Periodicals: Publishing Or Publishing & Printing (2721)

akta.pro primary industry

Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)

akta.pro secondary industries

Medical Affairs Scientific Communications (MSL Support/Scientific Response) (HLAGALAF), Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB)

Keywords

• Medical media publishing
• Physician recruitment services
• Clinic succession brokerage
• Continuing medical education
• Pharmaceutical advertising

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Recruitment Services (有料職業紹介事業): Physician job placement and career transition support services for medical institutions. Licensed by Ministry of Health, Labour and Welfare (license no. 13-ユ-308085). The company earns placement fees from healthcare facilities that hire physicians through the platform. Services are free for physicians.
2. Clinic Succession Support (継承支援): Clinic ownership transfer and business succession brokerage services connecting retiring physicians with successor doctors. The company supports both sellers and buyers of medical clinic businesses through the Medical Tribune NEXT platform.
3. Advertising & Promotion Services for Pharma/Healthcare Companies: Digital and print advertising, multi-channel promotions, survey/oncolytics research reports, and e-detail services targeting physicians. Revenue from pharmaceutical companies, medical device manufacturers, and healthcare general enterprises.
4. Publishing & Content Distribution: Medical newspaper (Medical Tribune), magazines, periodic and non-periodic publications, books, and web media content. Revenue from subscriptions, newsstand sales, and content licensing.
5. Events & Conventions: Planning, organization, and operation of medical seminars, symposiums, and conferences. Also includes webinar production and distribution of clinical video content.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Core offering

Medical Tribune is a Japanese medical media company that publishes daily medical news, clinical research content, and specialty healthcare information through its owned web platform (Medical Tribune Web), weekly newspaper, webinars, and PubMed-based research tools. The company also operates physician recruitment (Medical Tribune Career), clinic succession brokerage (Medical Tribune NEXT), and continuing medical education (MT-MEET) services, monetizing primarily through B2B pharmaceutical advertising, placement fees paid by healthcare facilities, and content subscriptions.

Product overview

Medical Tribune operates as a comprehensive medical media platform consisting of a main web platform (Medical Tribune ウェブ) complemented by specialized sub-brands and modules. The core offering includes medical news and expert commentary (Doctor's Eye, MT Case Reports), while specialized channels cover oncology (オンコロジートリビューン) and pharmacy (ファーマトリビューン). Supplementary services include physician career support (Medical Tribune Career), clinic succession assistance (Medical Tribune NEXT), AI-enhanced PubMed search (エビでやんす), clinical webinars (MT医療ウェビナー), pharmaceutical data (添付文書・処方数量統計データ), and rapid drug approval updates (新薬エクスプレス). The platform serves Japanese medical professionals across multiple touchpoints from news consumption to career development and continuing education.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Tribune Web Platform A comprehensive medical news and information web platform serving Japanese healthcare professionals with daily news articles, expert commentary series, specialty content across oncology, infectious disease, obesity/diabetes, ophthalmology, and rare diseases, plus AI-powered research tools. Free registration required for full access.
• Medical Tribune Career Physician recruitment and job change support service connecting medical professionals with healthcare facilities across Japan. Offers approximately 10,868 active job listings, consultant-assisted job matching, and career consultation. Free for physicians; healthcare facilities pay placement fees upon successful hiring. Licensed by Ministry of Health, Labour and Welfare (license no. 13-ユ-308085).
• Medical Tribune NEXT Clinic succession and inheritance brokerage service that matches physicians seeking to take over existing medical practices with clinic owners planning retirement, facilitating business continuity in local healthcare. Features 115+ listed succession properties. Free initial consultation; company earns success fees on completed transactions.
• MT-MEET Lifetime education website for physicians offering CME courses, professional development content, and live clinical lecture webinars with interactive features for medical professionals.
• Medical Tribune Newspaper (週刊医学新聞) Weekly Japanese-language medical newspaper distributed to physicians, hospitals, and medical institutions. Established in 1968, available in both physical and digital subscription formats.
• Oncology Tribune (オンコロジートリビューン) Oncology-focused news and information channel providing specialized coverage of cancer research, treatments, and oncology news for healthcare professionals.
• Pharma Tribune (ファーマトリビューン) Pharmacy-focused news channel delivering pharmaceutical industry updates, drug approvals, and pharmacist-relevant information targeted at pharmacy professionals.
• Pharmaceutical Advertising & Promotion Services Digital and print advertising, multi-channel promotions, survey/oncology research reports, and e-detail services for pharmaceutical companies, medical device manufacturers, and healthcare general enterprises. Provides access to verified physician audiences.
• Medical Events & Conventions Planning, organization, and operation of medical seminars, symposiums, conferences, and webinar production. Includes on-site conference coverage of major Japanese medical society meetings.

Quantifiable outcome

• Early resignation rate of placed physicians below 5% vs. ~13% industry average
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability2 records

Feature3 records

Partnerships

One partnership is on record.

• Alfresa Corporation (アルフレッサ株式会社)coreStrategic or Co-development Partner · 1 June 2026Strategic business partnership announced June 1, 2026. Alfresa is one of Japan's largest pharmaceutical wholesale/distribution companies. The partnership enables Medical Tribune to strengthen its pharmaceutical industry information and promotion services, likely expanding reach to pharmaceutical companies and healthcare enterprises through Alfresa's distribution network.

Scale indicators6 records

Recent moves21 records

Expansion highlights5 records

Direct peers

• M3 Inc. Japan's dominant physician platform operating m3.com, MR-kun detailing services, and physician recruitment. Directly comparable to Medical Tribune as a physician audience aggregator monetized through pharma marketing, recruitment, and clinical content — but at materially larger scale.
• MedPeer Inc. Japanese physician community platform offering clinical Q&A, case discussions, drug information, and survey panels. Comparable to Medical Tribune's physician community, content, and pharma market-research monetization, with stronger community/UGC focus.
• CareNet Inc. Japanese medical information site for physicians offering clinical content, medical news, and educational services. Closely overlaps Medical Tribune's editorial and CME offerings, targeting the same physician audience with similar B2B pharma monetization.
• Nikkei Medical (Nikkei BP): Medical news and information portal operated by Nikkei BP, one of Japan's largest B2B media groups. Direct competitor in Japanese physician media, with comparable clinical content, news, and B2B pharma marketing channels.
• Nankodo Co., Ltd. (南江堂): Established Japanese medical and healthcare publisher producing textbooks, journals, and clinical references. Comparable to Medical Tribune in medical publishing heritage and physician-targeted content.
• Igaku Shoin (医学書院): Long-established Japanese medical publisher of clinical journals, textbooks, and periodicals serving physicians and healthcare professionals. Comparable to Medical Tribune's publishing heritage, medical journalism, and CME content offerings.
• Iyaku Journal Co., Ltd. (医薬ジャーナル): Japanese medical periodical publisher focused on clinical and pharmaceutical journalism. Directly comparable in business model and audience to Medical Tribune's print periodicals and web publishing operations.

Broad incumbents

• Springer Healthcare Japan: Global medical communications and publishing group with Japan presence offering medical affairs, publications, and educational services. Comparable to Medical Tribune's medical affairs and CME offerings as part of a broader international portfolio.
• Elsevier (Japan): Global medical and scientific publisher with Japan operations covering clinical journals, decision-support tools, and pharma marketing services. Broadly comparable to Medical Tribune's scholarly content and pharma services through a wider portfolio at much larger scale.

Emerging players

• Doctors Square Inc. Japanese physician-focused platform covering community, career content, and medical practice support. Comparable to Medical Tribune's physician community and career content offerings as a smaller, emerging alternative.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/mtpronews

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Tribune